Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
University of Pittsburgh
Genentech, Inc.
Keythera (Suzhou) Pharmaceuticals Co. Ltd
Academic and Community Cancer Research United
Amgen
Hoffmann-La Roche
Asan Medical Center
Gruppo Oncologico del Nord-Ovest
Fate Therapeutics
Hoffmann-La Roche
Hoffmann-La Roche